Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-23 22:54 | 2019-09-20 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $117.00 | 4,500 | $526,500 | 33,806 | -11.7% |
| 2019-09-09 18:59 | 2019-09-03 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $112.96 | 19,500 | $2,202,714 | 38,306 | -33.7% |
| 2019-09-09 19:12 | 2019-09-05 | LLY | ELI LILLY & Co | Fry Stephen F | Officer; SVP, HR & Diversity | Pharmaceutical Preparations | SALE | $115.00 | 9,452 | $1,086,980 | 100,211 | -8.6% |
| 2019-09-04 22:09 | 2019-09-03 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $112.91 | 19,500 | $2,201,745 | 38,306 | -33.7% |
| 2019-07-15 22:46 | 2019-07-15 | LLY | ELI LILLY & Co | Smiley Joshua L | Officer; SVP and CFO | Pharmaceutical Preparations | BUY | $108.47 | 185 | $20,067 | 30,595 | +0.6% |
| 2019-06-05 21:15 | 2019-06-05 | LLY | ELI LILLY & Co | Smiley Joshua L | Officer; SVP and CFO | Pharmaceutical Preparations | BUY | $118.03 | 426 | $50,281 | 30,410 | +1.4% |
| 2019-06-04 20:57 | 2019-06-03 | LLY | ELI LILLY & Co | Harrington Michael J | Officer; Senior VP and General Counsel | Pharmaceutical Preparations | SALE | $116.72 | 16,000 | $1,867,520 | 110,300 | -12.7% |
| 2019-05-16 23:44 | 2019-05-03 | LLY | ELI LILLY & Co | Shaw Christi | Officer; SVP and Pres., Lilly Bio-Meds | Pharmaceutical Preparations | SALE | $117.08 | 7,077 | $828,575 | 500 | -93.4% |
| 2019-05-07 21:18 | 2019-05-03 | LLY | ELI LILLY & Co | Shaw Christi | Officer; SVP and Pres., Lilly Bio-Meds | Pharmaceutical Preparations | SALE | $117.14 | 7,577 | $887,571 | 0 | -100.0% |
| 2019-04-16 21:48 | 2019-04-12 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $124.65 | 10,000 | $1,246,500 | 57,806 | -14.7% |
| 2019-04-16 21:36 | 2019-04-12 | LLY | ELI LILLY & Co | Barnes Melissa S | Officer; Chief Eth/Cmpl Ofcr & SVP, ERM | Pharmaceutical Preparations | SALE | $125.15 | 4,735 | $592,585 | 22,085 | -17.7% |
| 2019-04-08 21:54 | 2019-04-05 | LLY | ELI LILLY & Co | Shah Aarti S. | Officer; SVP & CIO | Pharmaceutical Preparations | SALE | $125.85 | 1,800 | $226,530 | 18,425 | -8.9% |
| 2019-03-27 21:57 | 2019-03-26 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $131.41 | 205,000 | $26,938,681 | 116,810,304 | -0.2% |
| 2019-03-22 22:16 | 2019-03-22 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $128.50 | 1,000 | $128,500 | 4,595 | -17.9% |
| 2019-03-13 19:47 | 2019-03-12 | LLY | ELI LILLY & Co | Fry Stephen F | Officer; SVP, HR & Diversity | Pharmaceutical Preparations | SALE | $123.16 | 14,847 | $1,828,557 | 109,663 | -11.9% |
| 2019-03-05 23:51 | 2019-03-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $127.01 | 1,000 | $127,010 | 5,595 | -15.2% |
| 2019-03-04 22:13 | 2019-03-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $128.43 | 210,000 | $26,971,224 | 117,015,304 | -0.2% |
| 2019-03-01 21:25 | 2019-02-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $126.73 | 200,000 | $25,345,020 | 117,225,304 | -0.2% |
| 2019-02-26 00:06 | 2019-02-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $124.19 | 195,000 | $24,217,635 | 117,425,304 | -0.2% |
| 2019-02-20 21:35 | 2019-02-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $122.48 | 205,000 | $25,108,523 | 117,620,304 | -0.2% |
| 2019-02-20 23:37 | 2019-02-15 | LLY | ELI LILLY & Co | Conterno Enrique A | Officer; SVP&Pres, LillyDiab & LillyUSA | Pharmaceutical Preparations | SALE | $121.00 | 25,000 | $3,025,000 | 132,962 | -15.8% |
| 2019-02-05 00:32 | 2019-01-31 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $120.00 | 4,000 | $480,000 | 41,224 | -8.8% |
| 2019-02-01 22:38 | 2018-04-16 | LLY | ELI LILLY & Co | Mahony Susan | Officer; SVP & Pres., Lilly Oncology | Pharmaceutical Preparations | SALE | $80.08 | 17,379 | $1,391,710 | 40,685 | -29.9% |
| 2019-02-01 23:02 | 2018-07-26 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $95.22 | 1,568 | $149,305 | 52,628 | +3.1% |
| 2019-01-18 21:14 | 2019-01-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $118.33 | 136,577 | $16,161,279 | 117,825,304 | -0.1% |
| 2019-01-17 21:15 | 2019-01-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $117.87 | 1,657 | $195,315 | 117,961,881 | 0.0% |
| 2019-01-16 22:36 | 2019-01-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $117.74 | 51,766 | $6,095,136 | 117,963,538 | 0.0% |
| 2018-12-12 23:15 | 2018-12-10 | LLY | ELI LILLY & Co | O'Neill Myles | Officer; SVP & Pres., Mfg. Operations | Pharmaceutical Preparations | SALE | $112.92 | 25,000 | $2,822,960 | 50,954 | -32.9% |
| 2018-12-06 23:43 | 2018-12-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $119.00 | 15,500 | $1,844,536 | 118,015,304 | 0.0% |
| 2018-11-30 19:52 | 2018-11-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $117.42 | 185,000 | $21,722,423 | 118,030,804 | -0.2% |
| 2018-11-29 18:55 | 2018-11-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $115.57 | 190,000 | $21,957,939 | 118,215,804 | -0.2% |
| 2018-11-20 22:40 | 2018-11-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $115.31 | 195,000 | $22,485,567 | 118,405,804 | -0.2% |
| 2018-11-19 21:53 | 2018-11-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $113.74 | 200,000 | $22,747,000 | 118,600,804 | -0.2% |
| 2018-11-14 18:44 | 2018-11-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $113.41 | 2,460 | $278,979 | 118,800,804 | 0.0% |
| 2018-11-13 18:51 | 2018-11-12 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $113.48 | 202,540 | $22,984,867 | 118,803,264 | -0.2% |
| 2018-10-18 21:26 | 2018-10-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $113.25 | 174,696 | $19,783,623 | 119,005,804 | -0.1% |
| 2018-10-10 20:17 | 2018-10-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $115.91 | 10,672 | $1,237,013 | 119,180,500 | 0.0% |
| 2018-10-09 20:14 | 2018-10-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $115.91 | 14,632 | $1,696,039 | 119,191,172 | 0.0% |
| 2018-10-05 21:47 | 2018-10-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $112.67 | 116,038 | $13,073,955 | 119,205,804 | -0.1% |
| 2018-10-05 21:08 | 2018-10-04 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $114.64 | 7,000 | $802,480 | 45,224 | -13.4% |
| 2018-10-04 21:29 | 2018-10-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $109.01 | 78,962 | $8,607,253 | 119,321,842 | -0.1% |
| 2018-10-01 18:53 | 2018-09-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $107.31 | 107,553 | $11,541,082 | 119,400,804 | -0.1% |
| 2018-09-28 17:36 | 2018-09-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $107.00 | 92,447 | $9,891,644 | 119,508,357 | -0.1% |
| 2018-09-27 19:26 | 2018-09-26 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $106.63 | 134,410 | $14,332,367 | 119,600,804 | -0.1% |
| 2018-09-26 20:49 | 2018-09-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $106.41 | 55,590 | $5,915,165 | 119,735,214 | 0.0% |
| 2018-09-20 00:47 | 2018-09-17 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $106.31 | 6,000 | $637,830 | 52,224 | -10.3% |
| 2018-09-10 19:44 | 2018-09-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $106.76 | 180,000 | $19,217,052 | 119,790,804 | -0.2% |
| 2018-09-04 23:50 | 2018-09-04 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $105.57 | 600 | $63,342 | 3,530 | -14.5% |
| 2018-08-31 16:07 | 2018-08-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $105.42 | 190,000 | $20,030,370 | 119,970,804 | -0.2% |
| 2018-08-21 21:12 | 2018-08-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $105.89 | 195,000 | $20,647,575 | 120,160,804 | -0.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.